VIVET ATTENDING WEDBUSH PACGROW 2018 HEALTHCARE CONFERENCE IN NEW YORK
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board.
PARIS, France June 12th, 2018, Vivet Therapeutics, a biotechnology company developing novel gene therapies for rare
Vivet attending BIO 2018 in Boston on June 4-7
Vivet’s CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1×1 meetings during BIO 2018 in Boston on June 4-7.
VIVET ANNOUNCES 2 PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 ASGCT ANNUAL MEETING
Vivet Therapeutics announces 2 presentations on its lead product
Vivet sponsoring and attending Wilson Disease Association (WDA) 2018 Annual Conference
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet announces presentation on its lead product at the upcoming 2018 International Liver Congress
Vivet Therapeutics announces presentation on its lead product at the upcoming
Vivet is sponsoring and attending the 9th Congress of the Spanish Society for Gene and Cell Therapy
Vivet is a gold sponsor of the
Vivet participating to a panel at 2018 Biotech & Money congress
ean-Philippe Combal, Vivet Therapeutics’ CEO
Vivet hosting meetings during JPM 2018 Healthcare Conference
Jean-Philippe Combal, Vivet Therapeutics’ CEO
Vivet attending Jefferies 2017 London Healthcare Conference
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during Jefferies 2017 London Healthcare Conference on…
